ArticleJournal of cellular and molecular medicine2014

HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.

Ruo-Chia Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.